Loading...
OTCMESLOY
Market cap109bUSD
Dec 20, Last price  
120.15USD
1D
-0.12%
1Q
5.97%
Jan 2017
112.54%
Name

EssilorLuxottica SA

Chart & Performance

D1W1MN
OTCM:ESLOY chart
P/E
22.92
P/S
2.07
EPS
5.02
Div Yield, %
0.89%
Shrs. gr., 5y
11.10%
Rev. gr., 5y
18.58%
Revenues
25.40b
+3.68%
2,260,376,0002,424,323,0002,689,958,0002,908,116,0003,074,419,0003,267,978,0003,891,559,0004,189,541,0004,989,000,0005,065,000,0005,670,000,0006,716,000,0007,115,000,0009,184,000,00010,833,000,00017,390,000,00014,429,000,00019,820,000,00024,494,000,00025,395,000,000
Net income
2.29b
+6.37%
244,427,000287,917,000328,733,000366,740,000382,356,000390,685,000461,969,000505,619,000584,000,000593,000,000929,000,000757,000,000813,000,000789,000,0001,083,000,0001,077,000,00085,000,0001,448,000,0002,152,000,0002,289,000,000
CFO
4.86b
+1.63%
403,899,000398,330,000451,061,000491,904,000496,801,000515,338,000619,453,000667,798,000839,998,000843,000,0001,032,000,0001,194,000,0001,194,000,0001,603,000,0002,359,000,0003,299,000,0002,952,000,0004,545,000,0004,783,000,0004,861,000,000
Dividend
May 03, 20242.11068 USD/sh
Earnings
Feb 12, 2025

Profile

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, Europe, Latin America, Asia, Oceania, and Africa. It operates in five segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale segment engages in the manufacture and wholesale distribution of luxury and sports eyewear. The Retail segment retails luxury and sports eyewear. The Lenses and Optical Instruments segment offers lenses and small equipment, including Varilux progressive lenses; Crizal antireflective, anti-smudge, and antistatic lenses; Transitions photochromic lenses; Eyezen lenses for users of computers, tablets, smartphones, and other connected devices; Xperio polarized sun lenses; and Nikon and Kodak corrective lens brands. It also provides lens edging and mounting instruments for opticians and prescription laboratories; optometry instruments for eye care professionals, schools, occupational medicine centers, military, and other institutions; and Transitions Signature Gen 8 photochromic lens, as well as develops solutions for online sales of optical products. The Equipment segment offers digital surfacing machines and lens coating machines to prescription laboratories, integrated optical chains, and lens manufacturers. The Sunglasses and Readers segment provides non-prescription sunglasses and reading glasses under the Foster Grant, Gargoyles, Magnivision, Corinne McCormack, Monkey Monkey, Ryders Eyewear, and SolarShield brands; Reebok, Steve Madden, Betsey Johnson, Nine West, Dockers, French Connection, Ironman, Rawlings, Bodyglove, Panama Jack, Marvel, and Disney; Bolon, Molsion, Qina, and Prosun brands; and Mujosh and Aojo brands. It has a network of 490 prescription laboratories and edging-mounting facilities. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.
URL
https://www.essilorluxottica.com/
IPO date
Jan 01, 1975
Employees
191,144
Domiciled in
FR
Incorporated in
FR

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
25,395,000
3.68%
24,494,000
23.58%
19,820,000
37.36%
Cost of revenue
21,991,000
21,051,000
17,350,000
Unusual Expense (Income)
NOPBT
3,404,000
3,443,000
2,470,000
NOPBT Margin
13.40%
14.06%
12.46%
Operating Taxes
609,000
751,000
583,000
Tax Rate
17.89%
21.81%
23.60%
NOPAT
2,795,000
2,692,000
1,887,000
Net income
2,289,000
6.37%
2,152,000
48.62%
1,448,000
1,603.53%
Dividends
(487,000)
(454,000)
(138,000)
Dividend yield
0.59%
0.60%
0.17%
Proceeds from repurchase of equity
(237,000)
(394,000)
(283,000)
BB yield
0.29%
0.52%
0.34%
Debt
Debt current
2,699,000
2,010,000
1,873,000
Long-term debt
12,198,000
10,194,000
11,143,000
Deferred revenue
15,000
27,000
27,000
Other long-term liabilities
787,000
3,264,000
3,139,000
Net debt
12,258,000
9,696,000
9,294,000
Cash flow
Cash from operating activities
4,861,000
4,783,000
4,545,000
CAPEX
(1,531,000)
(1,572,000)
(1,030,000)
Cash from investing activities
(1,724,000)
(3,293,000)
(8,127,000)
Cash from financing activities
(2,361,000)
(2,906,000)
(1,973,000)
FCF
1,619,000
2,076,000
(153,000)
Balance
Cash
2,559,000
1,989,000
3,335,000
Long term investments
80,000
519,000
387,000
Excess cash
1,369,250
1,283,300
2,731,000
Stockholders' equity
16,322,000
15,441,000
13,725,000
Invested Capital
49,966,750
49,311,700
46,291,000
ROIC
5.63%
5.63%
4.56%
ROCE
6.36%
6.50%
4.79%
EV
Common stock shares outstanding
450,766
445,659
445,467
Price
181.60
7.33%
169.20
-9.63%
187.24
46.80%
Market cap
81,859,081
8.56%
75,405,544
-9.60%
83,409,277
48.96%
EV
94,770,081
85,793,544
93,514,277
EBITDA
6,376,000
6,364,000
4,857,000
EV/EBITDA
14.86
13.48
19.25
Interest
198,000
156,000
141,000
Interest/NOPBT
5.82%
4.53%
5.71%